Trials / Terminated
TerminatedNCT01870245
A Multiple Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of ACHN-975 in Healthy Volunteers
A Phase 1 Multiple Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of ACHN-975 Administered Intravenously to Healthy Volunteers
- Status
- Terminated
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 4 (actual)
- Sponsor
- Achaogen, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
This is a randomized, double-blind, placebo-controlled, multiple-dose study, designed to assess the safety, tolerability, and pharmacokinetics (PK) of ACHN-975. This study will take place in the US at one clinical site.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ACHN-975 | Intravenous multiple dose |
| DRUG | placebo | Intravenous multiple dose |
Timeline
- Start date
- 2013-05-01
- Primary completion
- 2013-06-01
- First posted
- 2013-06-06
- Last updated
- 2013-07-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01870245. Inclusion in this directory is not an endorsement.